NABP study for FDA shows most patients receive drug information but quality varies

被引:0
|
作者
不详
机构
关键词
D O I
10.1093/ajhp/57.6.519
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:519 / +
页数:2
相关论文
共 50 条
  • [42] Using web-based quality data to choose a primary care physician: Which information do patients rely on most
    Fanjiang, G.
    Von Glahn, T.
    Chang, H.
    Rogers, W.
    Safran, D.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 159 - 159
  • [43] Impact of Urine Drug Screening on No Shows and Dropouts among Chronic Pain Patients: A Propensity-Matched Cohort Study
    Krishnamurthy, Parthasarathy
    Ranganathan, Govindaraj
    Williams, Courtney
    Doulatram, Gulshan
    PAIN PHYSICIAN, 2016, 19 (02) : 89 - 100
  • [44] Quality assurance practices for pharmaceutical industry-based drug information departments: A review and case study
    Fung, SM
    Martin, JS
    DRUG INFORMATION JOURNAL, 2004, 38 (04): : 395 - 405
  • [45] Quality Assurance Practices for Pharmaceutical Industry-Based Drug Information Departments: A Review and Case Study
    Stacey M. Fung
    Joyce Serrano Martin
    Drug information journal : DIJ / Drug Information Association, 2004, 38 (4): : 395 - 405
  • [46] Relationship Between Time Consumption and Quality of Responses to Drug-related Queries: A Study From Seven Drug Information Centers in Scandinavia
    Reppe, Linda Amundstuen
    Lydersen, Stian
    Schjott, Jan
    Damkier, Per
    Christensen, Hanne Rolighed
    Kampmann, Jens Peter
    Bottiger, Ylva
    Spigset, Olav
    CLINICAL THERAPEUTICS, 2016, 38 (07) : 1738 - 1749
  • [47] Study of the quality of information given to patients participating in a clinical trial regarding chronic hemodialysis
    Lynöe, N
    Näsström, B
    Sandlund, M
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2004, 38 (06): : 517 - 520
  • [48] Risk of drug-induced delirium in older patients- a pharmacovigilance study of FDA adverse event reporting system database
    Jia, Boying
    Zhou, Shuang
    Li, Jiayu
    Wan, Liyan
    Zhou, Ying
    Cui, Yimin
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (01) : 79 - 87
  • [49] Cancer patients' preferences for communicating clinical trial quality of life information: A qualitative study
    Brundage, M
    Leis, A
    Bezjak, A
    Feldman-Stewart, D
    Degner, L
    Velji, K
    Zetes-Zanatta, L
    Tu, D
    Ritvo, P
    Pater, J
    QUALITY OF LIFE RESEARCH, 2003, 12 (04) : 395 - 404
  • [50] The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study
    Maurer, Marcus
    Weller, Karsten
    Magerl, Markus
    Maurer, Rasmus Robin
    Vanegas, Emanuel
    Felix, Miguel
    Cherrez, Annia
    Mata, Valeria L.
    Kasperska-Zajac, Alicja
    Sikora, Agnieszka
    Fomina, Daria
    Kovalkova, Elena
    Godse, Kiran
    Rao, Nimmagadda Dheeraj
    Khoshkhui, Maryam
    Rastgoo, Sahar
    Jardim Criado, Roberta Fachini
    Abuzakouk, Mohamed
    Grandon, Deepa
    van Doorn, Martijn
    Valle, Solange Olliveira Rodrigues
    Lima, Eduardo Magalhaes de Souza
    Thomsen, Simon Francis
    Ramon, German D.
    Benavides, Edgar E. Matos
    Bauer, Andrea
    Gimenez-Arnau, Ana Maria
    Kocaturk, Emek
    Guillet, Carole
    Larco, Jose Ignacio
    Zhao, Zuo-Tao
    Makris, Michael
    Ritchie, Carla
    Xepapadakia, Paraskevi
    Ensina, Luis Felipe
    Cherrez, Sofia
    Cherrez-Ojeda, Ivan
    WORLD ALLERGY ORGANIZATION JOURNAL, 2020, 13 (11):